Pharmaceutical supply contracts

BARMER Beschaffung und Vergabe·Wuppertal, Germany·Deadline May 01, 2028 · 613 days left·Open·Supplies·Framework

Zarejestruj się, aby zapisać

Structured notice only

Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittelverträge mit Beitrittsoption

35/100

Ocena szansy

Needs reviewMedium complexity

SuppliesFrameworkOpen

Skąd ta ocena?

Szansa

35 / 100

Złożoność

40 / 100

Czynniki ryzyka

Absence of estimated value or framework maximum makes it impossible to gauge potential revenue or pricing expectations.

The notice explicitly states it is not subject to EU procurement directives or German competition law (Kartellvergabere...

No procurement documents available

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

Framework procurement
Supplies contract
3 lots
Duration until Jun 2028
Supply of pharmaceutical products for 5 specific active ingredients as defined in each lot.
Framework agreement with accession option, allowing additional parties to join the contract.

Pokaż pełne podsumowanie

This is a framework agreement with accession option (Rahmenvertrag mit Beitrittsoption) for pharmaceutical products issued by BARMER, a German statutory health insurance company. It covers 5 lots for specific active ingredients: Bimatoprost, Calcipotriol + Betamethasone dipropionate, Eltrombopag (excluding SAA), Eltrombopag (Revolade®), and Nintedanib. The contract is structured as a 2-year framework (2026-06-01 to 2028-06-30) with a possible 3-month extension. The notice is not a public procurement under EU law and is published voluntarily. Estimated value is not provided. The procedure is open, and submissions must be electronic via the buyer's portal. The tender is in German only. No award criteria or selection criteria are specified in the available data.

Ryzyka

Absence of estimated value or framework maximum makes it impossible to gauge potential revenue or pricing expectations.

The notice explicitly states it is not subject to EU procurement directives or German competition law (Kartellvergabere...

No procurement documents available

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Administrative

Tenders must be submitted electronically via the buyer's portal at Otwórz portal
All documents must be in German; no other languages are accepted.
Maximum of 5 lots can be awarded and submitted.

Wymagania mogą być niepełne.

Zamawiający

Nazwa

BARMER Beschaffung und Vergabe

Lokalizacja

Wuppertal, Germany

Czas trwania

May 2026 - Jun 2028

Kategoria

Pharmaceutical products

Szczegóły zamówienia

Data publikacji: 13 Apr 2026
Języki: German

Metadane referencyjne

Podstawa prawna: 32014L0024

Identyfikatory referencyjne

ID przetargu: 252831-2026

Dokumenty (1)

Portal składania ofert 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27